Clinical Trial Study App for the KRYSTAL-12 study. Enables study participants to complete eDiary entries, view scheduled appointments, receive alerts, and access resources about the study.
The KRYSTAL-12 app is tailored for the Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation, protocol number 849-012.
The KRYSTAL-12 app is tailored for the Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation, protocol number 849-012.
Show More
